Thursday, July 17, 2025
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home 2023 June

Monthly Archives: June 2023

2023 Watch List

Report: Is Psycheceutical BioScience (BWVI) One of the Most Important Companies...

Editor / Curator -
All News

Is Ultra-Shear’s™ Nano-THC the Most Powerful and Fast-Acting THC in the...

Editor / Curator -
Psychedelic Stock Review

Billionaire, Point 72’s Steve Cohen, Continues to Support Psychedelic Research.

Editor / Curator -
Biotech News

Scientists Pinpoint Location of Plaque Ruptures..

Editor / Curator -
2021 Watch List

Hepion Pharmaceuticals (HEPA) Announces Passing of Key Safety Milestone in Phase...

Editor / Curator -
Psychedelic News

Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within...

Editor / Curator -
2023 Watch List

Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials

Editor / Curator -
2023 Watch List

Hepion Pharma (HEPA). Artificial Intelligence (AI) to Speed Drug Development.

Editor / Curator -
Client

Acquisition of Certain Minerva-Rockdale Oil and Gas Leases and Field Equipment...

Editor / Curator -
Client

Principal Solar Comments on SEC Action

Editor / Curator -
12Page 1 of 2

Latest article

Road Trip to Nevada, to Meet World Renowned Geologist, Dr. Sergei Diakov.

All News Editor / Curator -
Adding Fairchild Gold (FAIR) $0.035 to the Watch List. The Thrilla and Manilla, and the Nirvana in Nevada. What does Manilla have to do with Nevada?...

Maxim Group, Critical Minerals Summit

All News Editor / Curator -
The group of 'Critical Minerals' companies in our Universe are on a tear. Learn more via this timely presentation put together by Maxim Group....

Adding Emergent Biosolutions (EBS) $6.95 to Watch List.

Uncategorized Editor / Curator -
LIVE QUOTE We originally heard about Emergent last February when it was hitting a new low, near $1.50. Within weeks it ran to $3.50 and...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.